Tousignant Jennifer
Insider CIK 2010978 · VRDN Chief Legal Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| VRDN Viridian Therapeutics, Inc | M Exercise deriv | 2026-08-19 | 2026-08-20 | 10,000 | — | $0 | 114,072 | SEC↗ |
| VRDN Viridian Therapeutics, Inc | S Sale | 2026-08-19 | 2026-08-20 | 4,212 | $24.50 | $103.2K | 0 | SEC↗ |
| VRDN Viridian Therapeutics, Inc | M Exercise | 2026-08-19 | 2026-08-20 | 10,000 | $14.41 | $144.1K | 10,000 | SEC↗ |
| VRDN Viridian Therapeutics, Inc | S Sale | 2026-08-19 | 2026-08-20 | 10,000 | $24.50 | $245.0K | 0 | SEC↗ |
| VRDN Viridian Therapeutics, Inc | M Exercise deriv | 2026-08-19 | 2026-08-20 | 10,000 | — | $0 | 114,072 | SEC↗ |
| VRDN Viridian Therapeutics, Inc | S Sale | 2026-08-19 | 2026-08-20 | 10,000 | $24.50 | $245.0K | 0 | SEC↗ |
| VRDN Viridian Therapeutics, Inc | M Exercise | 2026-08-19 | 2026-08-20 | 10,000 | $14.41 | $144.1K | 10,000 | SEC↗ |
| VRDN Viridian Therapeutics, Inc | S Sale | 2026-08-19 | 2026-08-20 | 4,212 | $24.50 | $103.2K | 0 | SEC↗ |
| VRDN Viridian Therapeutics, Inc | M Exercise deriv | 2026-03-03 | 2026-03-04 | 5,169 | — | $0 | 15,510 | SEC↗ |
| VRDN Viridian Therapeutics, Inc | F Tax w/h | 2026-03-03 | 2026-03-04 | 1,724 | $29.32 | $50.5K | 3,445 | SEC↗ |
| VRDN Viridian Therapeutics, Inc | M Exercise | 2026-03-03 | 2026-03-04 | 5,169 | — | $0 | 5,169 | SEC↗ |
| VRDN Viridian Therapeutics, Inc | F Tax w/h | 2026-03-03 | 2026-03-09 | 1,675 | $30.19 | $50.6K | 3,494 | SEC↗ |
| VRDN Viridian Therapeutics, Inc | A Award deriv | 2026-03-02 | 2026-03-04 | 23,850 | — | $0 | 23,850 | SEC↗ |
| VRDN Viridian Therapeutics, Inc | A Award deriv | 2026-03-02 | 2026-03-04 | 119,300 | — | $0 | 119,300 | SEC↗ |
| VRDN Viridian Therapeutics, Inc | S Sale | 2025-12-31 | 2026-01-02 | 2,272 | $31.16 | $70.8K | 0 | SEC↗ |
| VRDN Viridian Therapeutics, Inc | A Award deriv | 2025-03-03 | 2025-03-04 | 124,072 | — | $0 | 124,072 | SEC↗ |
| VRDN Viridian Therapeutics, Inc | A Award deriv | 2025-03-03 | 2025-03-04 | 20,679 | — | $0 | 20,679 | SEC↗ |
| VRDN Viridian Therapeutics, Inc | A Award deriv | 2024-02-12 | 2024-02-14 | 290,000 | — | $0 | 290,000 | SEC↗ |